Corporate DealsNov 24, 2025 · 3:34pm ET
PMCBPharmaCyte Biotech, Inc. Common Stock
PharmaCyte Biotech Monetizes Stake in Femasys
Company strengthens cash position through strategic capital deployment.
Corporate DealsNov 24, 2025 · 3:34pm ET
PMCBPharmaCyte Biotech, Inc. Common Stock+84.5%
PharmaCyte Biotech Monetizes Stake in Femasys